iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
Back by popular demand! Leading experts, Dr. Mark Trail and Dr. Axel Gräwingholt, will return to our virtual stage on Monday, July 18 at 9 am PT/12 noon ET/6 pm CEST for an encore “ProFound Insights, ProFound Impact” event and clinical case study review.
From the world leader in artificial intelligence for breast imaging, discover the ProFound impact iCAD’s award-winning portfolio of cancer detection, density assessment, and risk evaluation solutions can have on your reading workflow.
iNFORMED - BlogInform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.View BlogMedia SpotlightThe New Normal - The Imaging Landscape in Late-Stage Pandemic DaysView ArticleClinical FeatureImproving reading time of digital breast tomosynthesis with concurrent computer aided detection.View White Paper
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.